H.R. 1254 would expand the list of substances regulated under the Controlled Substances
Act (title II of Public Law 91-513, the Comprehensive Drug Abuse Prevention and Control
Act of 1970) to include cannabimimetic agents, chemicals that are commonly known as
synthetic drugs. As a result, the government might be able to pursue cases involving drug
use that it otherwise would not be able to prosecute.
Because those prosecuted and convicted under H.R. 1254 could be subject to criminal
fines, the federal government might collect additional fines if the legislation is enacted.
Criminal fines are recorded as revenues, deposited in the Crime Victims Fund, and later
spent. (As of August 2010, the Fund balance had reached over 4 billion dollars and includes deposits from federal criminal fines, forfeited bail bonds, penalties, and special assessments collected by U.S. Attorneys’ Offices, federal U.S. courts, and the Federal Bureau of Prisons.) CBO expects that any additional revenues and direct spending would not be
significant because of the small number of cases likely to be affected.
CBO Cost Est
Sponsor: Rep. Charles Dent [R-PA15]
Synthetic Drug Control Act of 2011 - Amends the Controlled Substances Act to add as schedule I controlled substances: (1) any material, compound, mixture, or preparation which contains cannabimimetic agents (or the salts, isomers, or salts of isomers thereof), including: -any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist -5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497) -5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog) -1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) -1-butyl-3-(1-naphthoyl)indole (JWH-073) -1-hexyl-3-(1-naphthoyl)indole (JWH-019) -1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200) -1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250) -1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081) -1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122) -1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398) -1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) -1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) -1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4) -1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-8) -1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203); and (2) the following hallucinogenic substances: -4-methylmethcathinone (Mephedrone) -3,4-methylenedioxypyrovalerone (MDPV) -3,4-methylenedioxymethcathinone (methylone) -Naphthylpyrovalerone (naphyrone) -4-fluoromethcathinone (flephedrone) -4-methoxymethcathinone (methedrone; Bk-PMMA) -Ethcathinone -3,4-methylenedioxyethcathinone (ethylone) -Beta-keto-N-methyl-3,4-benzodioxyolybutanamine (butylone) -N,N-dimethylcathinone (metamfepramone) -Alpha-pyrrolidinopropiophenone (alpha-PPP) -4-methoxy-alpha-pyrrolidinopropiophenone (MOPPP) -3,4-methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) -Alpha-pyrrolidinovalerophenone (alpha-PVP) -6,7-dihydro-5H-indeno(5,6-d)-1,3-dioxal-6-amine) (MDAI). Extends the period for which the Attorney General may temporarily schedule a substance in schedule I to avoid an imminent hazard to public safety to two years with a one-year extension (currently, one year with a six-month extension).[/size]
Edited by c2288420, 16 November 2011 - 09:07 PM.